Tuesday, November 19, 2024
HomeTagsPreventive Treatment

Preventive Treatment

CSL Announces Positive Top-Line Phase 3 Results for Garadacimab

Global biotechnology leader CSL announced positive top-line Phase 3 results for garadacimab (CSL312), the company's investigational first-in-class monoclonal antibody inhibiting Factor XIIa being developed...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics